Clinical Trials Insight: 700053114

Trial Profile

Clinical Trials Insight: 700053114

Phase of Trial: Phase I

Latest Information Update: 02 Feb 2010

At a glance

  • Drugs Ropeginterferon alfa-2b (Primary)
  • Indications Hepatitis B; Hepatitis C
  • Focus Adverse reactions
  • Sponsors PharmaEssentia Corporation
  • Most Recent Events

    • 02 Feb 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top